The soft coral genus Sarcophyton contains the enzymatic machinery to synthesize a multitude of cembrene-type diterpenes. Herein, highly oxygenated cembrenoids, sarcoconvolutum A–E (1–5) were purified and characterized from an ethyl acetate extract of the red sea soft coral, Sarcophyton convolutum. Compounds were assemblies according to spectroscopic methods including FTIR, 1D- and 2D-NMR as well as HRMS. Metabolite cytotoxicity was tested against lung adenocarcinoma, cervical cancer, and oral-cavity carcinoma (A549, HeLa and HSC-2, respectively). The most cytotoxic compound, (4) was observed to be active against cell lines A549 and HSC-2 with IC50 values of 49.70 and 53.17 μM, respectively.
Natural products and chemical analogues are widely used in drug discovery, notably in cancer and infectious disease pharmacotherapy. Sarcophyton convolutum (Alcyoniidae) a Red Sea–derived soft coral has been shown to be a rich source of macrocyclic diterpenes and cyclized derivatives. Two previously undescribed polyoxygenated cembrane-type diterpenoids, sarcoconvolutums F (1) and G (2), as well as four identified analogues (3–6) together with a furan derivate (7) were isolated from a solvent extract. Compounds were identified by spectroscopic techniques, including NMR, HREIMS, and CD, together with close spectral comparisons of previously published data. Sarcoconvolutum F (1) contains a rare 1-peroxid-15-hydroxy-10-ene functionality. Isolated metabolites (1–7) were screened against lung adenocarcinoma (A549), cervical cancer (HeLa) and oral cavity carcinoma (HSC-2) lines. Compound 4 exhibited an IC50 56 µM and 55 µM against A549 and HSC-2 cells, respectively.
Sarcophyton Convolutum extract (S) is rich source of bioactive secondary metabolite. In this article we report identification of major components and study antimicrobial, anticancer and antiviral activities of non-polar Sarcophyton Convolutum extract. Results demonstrated that S. Convolutum extract (S) has strong bactericidal effect against P. aeruginosa ATCC 15442 recording MIC value about 0.05µg/mL. S. Convolutum extract (S) showed cytotoxicity against hepatocellular carcinoma cell line (HepG2), human colorectal adenocarcinoma (CaCo2), breast cancer cell line (MCF-7), and pulmonary adenocarcinoma (A549) and recorded IC50 of 102.73, 100.62, 86.68 and 81.64 while antiviral activity towards HSV-1 and HAV virus at the maximum nontoxic concentration was 32.69% and 11.53%, respectively. GCMS analysis of S. Convolutum extract (S) showed about 25 compounds about 45.31% of extract is sesquiterpene, 47.53 % fatty acid derivatives 3.13% steroids and 2.2% is retinal diterpene. Our in vitro study indicates that sesquiterpene rich softcoral S. Convolutum extract (S) is a promising anticancer and antimicrobial agent but weak antiviral agent.